Can Bruce
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
Papers in ⓘ
-
- Lipid Membrane Structure and Behavior 4
- Surgery 14
- Lipoproteins and Cardiovascular Health 8
- Cholesterol and Lipid Metabolism 5
- Co-authors
- Alan R. Tall (17 shared papers)Xian‐Cheng Jiang (5 shared papers)Shaobin Zhong (3 shared papers)Jan L. Breslow (4 shared papers)John Grove (1 shared paper)Katsuhiko Yano (1 shared paper)D. S. Sharp (1 shared paper)J. David Curb (1 shared paper)
- Journals
- Journal of Clinical Investigation (5 papers)Journal of Lipid Research (5 papers)Journal of Biological Chemistry (4 papers)Journal of Clinical Oncology (2 papers)Frontiers in bioscience (1 paper)
- Partner nations
- United StatesUnited KingdomItaly
In The Last Decade
Can Bruce
41 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Endocrinology, Diabetes and Metabolism 1.1k
- Cancer Research 552
- Surgery 1.5k
- Biochemistry 171
- Clinical Biochemistry 149
Countries citing papers authored by Can Bruce
This map shows the geographic impact of Can Bruce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Bruce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Bruce more than expected).
Fields of papers citing papers by Can Bruce
This network shows the impact of papers produced by Can Bruce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Bruce. The network helps show where Can Bruce may publish in the future.
Co-authors
The 25 scholars most cited alongside Can Bruce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. Hit paper breakdown → | 1996 | 469 |
| 2 | 2007 | 389 | |
| 3 | 1999 | 318 | |
| 4 | 1998 | 218 | |
| 5 | 1999 | 181 | |
| 6 | 1996 | 159 | |
| 7 | 1998 | 122 | |
| 8 | 1995 | 91 | |
| 9 | 2000 | 91 | |
| 10 | 2009 | 85 | |
| 11 | 1986 | 78 | |
| 12 | 1998 | 77 | |
| 13 | 2012 | 75 | |
| 14 | 2013 | 74 | |
| 15 | 1994 | 72 | |
| 16 | 1995 | 68 | |
| 17 | 2012 | 61 | |
| 18 | 2004 | 54 | |
| 19 | 2011 | 53 | |
| 20 | 2010 | 52 |
About Can Bruce
Can Bruce is a scholar working on Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism, Oncology and Clinical Biochemistry, having authored 41 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Cholesterol and Lipid Metabolism (5 papers), Cancer, Lipids, and Metabolism (4 papers), Lipid Membrane Structure and Behavior (4 papers), Advanced Proteomics Techniques and Applications (4 papers), Mass Spectrometry Techniques and Applications (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Cancer Research (552 citations), Surgery (1.5k citations), Biochemistry (171 citations) and Clinical Biochemistry (149 citations). Can Bruce has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Alan R. Tall, Xian‐Cheng Jiang, Shaobin Zhong, Jan L. Breslow, John Grove, Katsuhiko Yano, D. S. Sharp, J. David Curb, Omar L. Francone and Min Lin. Their work appears in journals such as Journal of Clinical Investigation, Journal of Lipid Research, Journal of Biological Chemistry, Journal of Clinical Oncology and Frontiers in bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.